Skip to search formSkip to main contentSkip to account menu

Zerit

Known as: Bristol-Myers Brand of Stavudine, Bristol-Myers Squibb Brand of Stavudine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
BACKGROUND Efavirenz is one of the most prescribed HIV drugs, it can have number of psychiatric adverse effects varying from… 
2008
2008
Background Generic antiretroviral therapy is the mainstay of HIV treatment in resource-limited settings, yet there is little… 
2007
2007
PURPOSE The aim of this study was to compare the single-dose oral bioavailability of two formulations of stavudine 40 mg capsules… 
2002
2002
  • E. Wooltorton
  • CMAJ : Canadian Medical Association journal…
  • 2002
  • Corpus ID: 43292647
Reason for posting: In a warning letter to physicians Bristol-Myers Squibb has reported 22 cases (including 7 deaths) worldwide… 
2002
2002
The author takes a comprehensive look at the governmenti?½s policy of technology transfer, the process by which government-funded… 
2000
2000
  • Stavudine Zerit
  • Research initiative, treatment action : RITA
  • 2000
  • Corpus ID: 35337423
Stavudine, an early nucleoside reverse transcriptase inhibitor (NRTI), was used as part of combination antiretroviral therapy for… 
Review
2000
Review
2000
A 58-year-old man, with HIV infections with a CD4 count of 162/mm3, an undetectable viral load, and no history of opportunistic… 
Highly Cited
1999
Highly Cited
1999
A 32-year-old African American woman with human immunodeficiency virus 1 (HIV-1) and a 3-year history of extensive facial… 
Review
1996
Review
1996
Stavudine, 2′,3′-didehydro-3′-deoxythymidine (D4T), has recently been approved by the U.S. Food and Drug Administration for the…